The Alliance for RTU” was founded in September 2024 by leading primary packaging manufacturers Gerresheimer (MDAX: GXI), SCHOTT Pharma (SDAX: 1SXP), and Stevanato Group (NYSE: STVN). The alliance will advance technical exchange and scientific developments related to ready-to-use (RTU) containers for sterile filling. The long-term aim is to transition to high-quality sterile packing, enhancing operational efficiency and patient safety.
ten23 health, the human-centric and sustainable strategic CDTMO partner of choice for the pharmaceutical industry and biotech start-ups, has joined the “Alliance for RTU“, an association to advance technical exchange for ready-to-use (RTU) containers in sterile manufacturing. The Alliance for RTU was formed in response to the market need for aseptic filling technologies and processes. It provides an expert platform to share expertise and technical knowledge on high-quality ready-to-fill sterile primary packaging with pharmaceutical companies, CMOs and CDMOs.
The vast experience of ten23 health in the development, sterile fill & finish (sterile manufacturing), and testing of sterile drug products using RTU container platforms makes the company a valuable addition to the Alliance. While RTU containers are an established format for syringes, the configuration also provides ample opportunities for vials and cartridges, as certain challenges persist for those container types.
By contributing the knowledge and expertise gained through a wide range of customer projects, ten23 aims to facilitate the further development and standardisation of RTU container platforms. This will improve efficiency and quality, while supporting regulatory compliance and promoting patient well-being.
